$0.3504
At close: Jun 18 EDT
$0.3246
-0.03-7.36%
Pre-Market: 6:22 AM EDT
Comments
Loading...
Cyclacel Pharmaceuticals Stock Guidance | NASDAQ:CYCC | Benzinga
Cyclacel Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cyclacel Pharmaceuticals Inc (CYCC) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for Cyclacel Pharmaceuticals (CYCC)?
There have been no specific sales or earnings guidance reported for Cyclacel Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.
